Answer
Liver function is monitored before and throughout fruquintinib treatment because liver test abnormalities, including fatal events, have been reported, and their severity and persistence may require withholding treatment, dose reduction or permanent discontinuation.
Sources for this answer
- FRUZAQLA 1 mg hard capsulesTakeda UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 3Document updated
Sources checked